Muscle News and Research

RSS

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.

22 Feb 2016

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Walking with a wearable robotic exoskeleton may enable people with multiple sclerosis to walk more efficiently by reducing the energy and muscle activity needed to walk, according to research presented this week at the Association for Academic Physiatrists Annual Meeting in Sacramento, Calif.

19 Feb 2016

Study looks at factors that affect physical recovery after participation in ultramarathon

Ultramarathon runners can expect an approximate five-to-seven-day subjective recovery post race, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif. The study also looked at factors that affect physical recovery and a runner's ability to return to full running speed after participation in an ultramarathon.

19 Feb 2016

SBP study opens door for new approaches to treat muscle diseases

Scientists at Sanford Burnham Prebys Medical Discovery Institute have found a key to enhancing repair of damaged muscle. In work published today in Cell Reports, scientists describe why fetal muscle stem cells (MuSCs) are better at regenerating muscle compared to adult MuSCs.

19 Feb 2016

Duke engineers develop technique to make artificial arteries that produce biochemical signals

Duke engineers have developed a technique to make artificial arteries that naturally produce biochemical signals vital to their functions. The technique is also ten times faster than current methods for tissue engineering of blood vessels.

19 Feb 2016

Neuroscientists identify specific enzyme that plays critical role in spinal muscular atrophy

Neuroscientists have discovered a specific enzyme that plays a critical role in spinal muscular atrophy, and that suppressing this enzyme's activity, could markedly reduce the disease's severity and improve patients' lifestyles.

19 Feb 2016

Revealing dynamic protein complexes with NMR: an interview with Elisar Barbar

Most proteins are involved in interactions with one or a few functional ligands, but some proteins, like light chain 8 (LC8), have numerous binding partners. LC8 interacts with more than 100 functionally different proteins, from viral proteins to motor proteins to proteins involved in cell division.

From Bruker BioSpin Group 18 Feb 2016

Zika virus can cross the placental barrier, according to new study

A study of pregnant women in Brazil has confirmed the presence of Zika virus in the amniotic fluid of two women who had displayed Zika-like symptoms during their pregnancies.

18 Feb 2016

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Motor skill training using a robotic arm exoskeleton may be beneficial to people suffering from post-stroke weakness affecting an entire side of their body, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

Early rehabilitation after traumatic spinal cord injury better for patients

Early rehabilitation following a traumatic spinal cord injury may lead to better functional outcomes for patients at the time of their discharge and in the subsequent year, according to research presented this week at the Association of Academic Physiatrists Annual Meeting in Sacramento, Calif.

18 Feb 2016

Antibiotics may be linked to delirium and other brain problems

Antibiotics may be linked to a serious disruption in brain function, called delirium, and other brain problems, more than previously thought, according to a "Views and Reviews" article published in the February 17, 2016, online issue of Neurology, a medical journal of the American Academy of Neurology.

18 Feb 2016

Study may lead to potential drug targets for tumor formation in pulmonary tuberous sclerosis complex

In a new study published in the American Association of Cancer Research's journal Cancer Research, a pair of investigators at Rutgers and Columbia universities has identified a gene that may provide a new source of potential drug targets for tumors that arise in pulmonary tuberous sclerosis complex (TSC).

18 Feb 2016

Magnesium therapy as a relaxing Mother’s day gift

This Mother’s Day, give the most important woman in your life one of the most powerful mineral relaxation rituals – magnesium therapy.

From BetterYou Ltd 17 Feb 2016

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

A small peptide dubbed TAxI is living up to its name. Recent studies show it to be an effective vehicle for shuttling functional proteins, such as active enzymes, into the spinal cord after a muscle injection.

17 Feb 2016

New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

With every heart attack, billions of cardiomyocytes, the contracting heart muscle cells that make the heart pump time after time over a lifetime, are lost which can lead to heart failure or injury. Stem cell-based replacement strategies could open new and much needed therapeutic avenues.

17 Feb 2016

Synthetic RNA and DNA could reverse protein deficiency that causes Friedreich's ataxia

Researchers at UT Southwestern Medical Center have identified synthetic RNA and DNA that reverses the protein deficiency causing Friedreich's ataxia, a neurological disease for which there is currently no cure.

17 Feb 2016

Physical therapy reduces urinary problems in postmenopausal women with osteoporosis

After menopause, women with osteoporosis struggle more with urinary incontinence than women with healthy bones do. But physical therapy that includes pelvic floor muscle training can produce dramatic improvements, shows a study published online today in Menopause, the journal of The North American Menopause Society.

17 Feb 2016

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Helsinn, the Swiss pharmaceutical Group focused on building quality cancer care, today announce that they have entered into distribution, license and supply agreements with Mundipharma and its network of independent associated companies granting exclusive rights to anamorelin in Norway, Finland, Sweden, Denmark and Iceland.

16 Feb 2016

Heart attack patients experiencing cardiogenic shock at higher risk of death in first 60 days post-discharge

Heart attack patients who experience cardiogenic shock have a higher risk of death or rehospitalization than non-shock patients in the first 60 days post-discharge, but by the end of the first year, the gap between the two groups narrows, according to a study published today in the Journal of the American College of Cardiology.

16 Feb 2016

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Delirium, muscle weakness and other neurological complications of sepsis often are overlooked and poorly understood, according to a study published in the journal Current Neurology and Neurosciences Reports.

16 Feb 2016

Muscle News and Research

Briviact (brivaracetam) approved for treatment of partial onset seizures in patients with epilepsy

Wearable robotic exoskeleton may enable multiple sclerosis patients to walk more efficiently

Study looks at factors that affect physical recovery after participation in ultramarathon

SBP study opens door for new approaches to treat muscle diseases

Duke engineers develop technique to make artificial arteries that produce biochemical signals

Neuroscientists identify specific enzyme that plays critical role in spinal muscular atrophy

Revealing dynamic protein complexes with NMR: an interview with Elisar Barbar

Zika virus can cross the placental barrier, according to new study

Motor skill training using exoskeleton device beneficial to people suffering from post-stroke weakness

Early rehabilitation after traumatic spinal cord injury better for patients

Antibiotics may be linked to delirium and other brain problems

Study may lead to potential drug targets for tumor formation in pulmonary tuberous sclerosis complex

Magnesium therapy as a relaxing Mother’s day gift

Small peptide TAxI holds promise for carrying biologic drugs into spinal cord

New study could help explain critical shortcomings in stem cell-driven therapies for heart disease

Synthetic RNA and DNA could reverse protein deficiency that causes Friedreich's ataxia

Physical therapy reduces urinary problems in postmenopausal women with osteoporosis

Helsinn, Mundipharma sign distribution, license and supply agreements for anamorelin

Heart attack patients experiencing cardiogenic shock at higher risk of death in first 60 days post-discharge

Study: Delirium, muscle weakness and other neurological complications of sepsis poorly understood

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News